Citation Impact
Citing Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
2000 Standout
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular Cancer
1987
Testicular Germ-Cell Cancer
1997 Standout
A view on drug resistance in cancer
2019 StandoutNature
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Diagnosis and management of refractoriness to platelet transfusion
2001
Head and neck cancer
2008 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Systematic review of amifostine for the management of oral mucositis in cancer patients
2012
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Neo‐adjuvant (Pre‐emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder
1991
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.
1994
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma
2006
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Chemotherapy and the war on cancer
2005 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
1992
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.
1991
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Microenvironmental regulation of metastasis
2008 Standout
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
2000
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
2006
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
1992
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.
1995
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.
1989
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
1990
Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review
2002
Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer
1991
Cancer of the Ovary
2004 Standout
Overview of Platelet Transfusion
2010
Doxorubicin (adriamycin) cardiomyopathy.
1983
Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications
2015 StandoutNobel
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]
1990 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Role of maintenance chemotherapy in acute promyelocytic leukemia
1987
Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study
2010
Acute Myeloid Leukemia
2015 Standout
Platelets and cancer
2002
Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
2005 Standout
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
1986
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
1993
Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With Cetuximab
2007
Metastatic Urothelial Cancer: Evaluation of Prognostic Factors and Change in Prognosis during the Last Twenty Years
2001
Curing metastatic testicular cancer
2002
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
1987 Standout
Pharmacological Effects of Formulation Vehicles
2003
Palliative Cancer Care a Decade Later: Accomplishments, the Need, Next Steps—From the American Society of Clinical Oncology
2009
Cancer treatment and survivorship statistics, 2016
2016 Standout
Fulminant Hepatitis: Mayo Clinic Experience With 34 Cases
1985
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.
1993
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
2002 Standout
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
2010 StandoutNobel
A mini-review on platelet refractoriness.
2005
The Role of Adjuvant Chemotherapy Following Cystectomy for Invasive Bladder Cancer: A Prospective Comparative Trial
1991
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
2005 Standout
Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study
1984
Ifosfamide in refractory male germ cell tumors.
1986
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
Prognostic factors for favorable outcome in disseminated germ cell tumors.
1986
Cisplatin
1984 Standout
Works of M. Troner being referenced
Percutaneous transhepatic insertion of a permanent prosthesis in the biliary tree. A new nonsurgical method for the relief of obstructive jaundice
1978
Successful Rechallenge with Etoposide Phosphate after an Acute Hypersensitivity Reaction to Etoposide
1999
Phase II Study of Tolerance and Efficacy of Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin, and Paclitaxel (Taxol) and Amifostine (Ethyol) in Head and Neck Squamous Cell Carcinomas
2005
Quality-of-Life Assessment After Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin, and Paclitaxel (Taxol) in Inoperable and/or Unresectable Head and Neck Squamous Cell Carcinoma
2005
Phase III Comparison of Cisplatin Alone Versus Cisplatin, Doxorubicin and Cyclophosphamide in the Treatment of Bladder (Urothelial) Cancer: A Southeastern Cancer Study Group Trial
1987
Immunological modification of adriamycin cardiotoxicity.
1980
Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Phase II study of etoposide for carcinoma of the prostate.
1986
The Role of Maintenance Therapy in Disseminated Testicular Cancer
1981